446 related articles for article (PubMed ID: 25996682)
21. Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M
Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110
[TBL] [Abstract][Full Text] [Related]
22. [Studies on gene expression and the 5' CpG islands methylation status of E-cadherin in acute myeloid leukemia].
Gao F; Li Y; Liu W; Lu XL; Li X; Wang PP; Liu YP
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):25-7. PubMed ID: 16732935
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
24. CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia.
Hájková H; Fritz MH; Haškovec C; Schwarz J; Šálek C; Marková J; Krejčík Z; Dostálová Merkerová M; Kostečka A; Vostrý M; Fuchs O; Michalová K; Cetkovský P; Beneš V
J Hematol Oncol; 2014 Sep; 7():66. PubMed ID: 25266220
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract][Full Text] [Related]
26. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki JR; Vincent PC; Clark SJ
Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-β and chemoresistance in acute myeloid leukemia.
Yang J; Xiao X; Li R; Li Z; Deng M; Zhang G
Cancer Biomark; 2016; 16(1):81-8. PubMed ID: 26835708
[TBL] [Abstract][Full Text] [Related]
28. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
[TBL] [Abstract][Full Text] [Related]
29. A Pilot Study of Aberrant CpG Island Hypermethylation of
Sun J; Zhang J; Wang Y; Li Y; Zhang R
Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
[No Abstract] [Full Text] [Related]
30. DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups.
Ohgami RS; Ma L; Ren L; Weinberg OK; Seetharam M; Gotlib JR; Arber DA
Br J Haematol; 2012 Oct; 159(2):182-90. PubMed ID: 22924777
[TBL] [Abstract][Full Text] [Related]
31. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.
Kroeger H; Jelinek J; Estécio MR; He R; Kondo K; Chung W; Zhang L; Shen L; Kantarjian HM; Bueso-Ramos CE; Issa JP
Blood; 2008 Aug; 112(4):1366-73. PubMed ID: 18523155
[TBL] [Abstract][Full Text] [Related]
32. Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome.
Fan R; Zhang LY; Wang H; Yang B; Han T; Zhao XL; Wang W; Wang XQ; Lin GW
Tohoku J Exp Med; 2012 Jun; 227(2):119-28. PubMed ID: 22706399
[TBL] [Abstract][Full Text] [Related]
33. MeDIP coupled with a promoter tiling array as a platform to investigate global DNA methylation patterns in AML cells.
Yalcin A; Kreutz C; Pfeifer D; Abdelkarim M; Klaus G; Timmer J; Lübbert M; Hackanson B
Leuk Res; 2013 Jan; 37(1):102-11. PubMed ID: 23062266
[TBL] [Abstract][Full Text] [Related]
34. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
35. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia.
Seedhouse CH; Das-Gupta EP; Russell NH
Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
Lenz G; Hutter G; Hiddemann W; Dreyling M
Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen.
Schmutz M; Zucknick M; Schlenk RF; Mertens D; Benner A; Weichenhan D; Mücke O; Döhner K; Plass C; Bullinger L; Claus R
Clin Epigenetics; 2023 Oct; 15(1):171. PubMed ID: 37885041
[TBL] [Abstract][Full Text] [Related]
38. p15 (INK4B) and E-cadherin CpG island methylation is frequent in Egyptian acute myeloid leukemia.
El-Shakankiry NH; Mossallam GI
J Egypt Natl Canc Inst; 2006 Sep; 18(3):227-32. PubMed ID: 17671532
[TBL] [Abstract][Full Text] [Related]
39. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
[TBL] [Abstract][Full Text] [Related]
40. [Analysis on promoter CpG methylation and expression of HOXB4 gene in cord blood CD34(+) cells and peripheral blood mononuclear cells].
Zheng CL; Guo ZX; Han ZC; Zhou YL; Lu SH; Ren Q; Lu M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):674-8. PubMed ID: 19549386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
